NIH trial data underpins FDA approval of omalizumab for food allergy
2024-02-16
(Press-News.org) Today’s Food and Drug Administration approval of a supplemental biologics license for the monoclonal antibody omalizumab (Xolair) highlights the vital role of the National Institutes of Health-supported research that underpins the FDA decision.
FDA has approved omalizumab for the reduction of allergic reactions, including anaphylaxis, that may occur with an accidental exposure to one or more foods in adults and children aged 1 year and older with food allergy. People taking omalizumab still need to avoid exposure to foods to which they are allergic. Omalizumab previously received FDA approval for three other indications, including the treatment of moderate-to-severe persistent allergic asthma in certain patients.
The new FDA approval is based on data from a planned interim analysis of a Phase 3 clinical trial sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of NIH. The trial is called Omalizumab as Monotherapy and as Adjunct Therapy to Multi-Allergen OIT in Food Allergic Children and Adults, or OUtMATCH. Investigators in the NIAID-funded Consortium for Food Allergy Research conducted the trial.
Detailed final results from the first stage of the trial will be presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting in Washington, D.C. during a late-breaking symposium titled, “Omalizumab for the Treatment of Food Allergy: The OUtMATCH Study” on Sunday, Feb. 25, 2024, at 1:45 pm ET. An online supplement of the Journal of Allergy and Clinical Immunology published an abstract outlining the final results on Feb. 5, 2024.
NIAID funds the trial with additional support from and collaboration with Genentech, a member of the Roche Group, and Novartis Pharmaceuticals Corporation. The two companies collaborate to develop and promote omalizumab and are supplying it for the trial.
Additional information about the ongoing OUtMATCH trial is available at ClinicalTrials.gov under study identifier NCT03881696.
Media inquiries can be directed to Laura Leifman at 301-402-1663, NIAIDNews@niaid.nih.gov.
NIAID conducts and supports research—at NIH, throughout the United States, and worldwide—to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID website.
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit https://www.nih.gov/.
NIH...Turning Discovery Into Health®
END
ELSE PRESS RELEASES FROM THIS DATE:
2024-02-16
TAMPA, Fla. — Penile squamous cell carcinoma is a rare malignancy with limited treatment options and poor prognosis, especially in advanced stages. Because of its rarity, few studies focus on better understanding and managing this disease. In a new article published in the Journal of the National Cancer Institute, Moffitt Cancer Center researchers share data on the efficacy and safety of neoadjuvant chemotherapy for locally advanced penile squamous cell carcinoma, addressing a critical gap in evidence regarding treatment options for this rare and aggressive cancer.
The Moffitt team, in collaboration with institutions across ...
2024-02-16
A new paper led by Harvard researchers has zeroed in on biomarkers of aging using omic data from population-based studies. The team, which included aging and longevity expert Alex Zhavoronkov, PhD, founder and CEO of AI-driven drug discovery company Insilico Medicine, provided a framework for standardizing the development and validation of biomarkers of aging to better predict longevity and quality of life. The findings appeared in Nature Medicine.
Biomarkers are biological characteristics that can be measured and used to evaluate various biological processes, ...
2024-02-16
Although primary open-angle glaucoma (POAG) is the leading cause of blindness in people over the age of 55, there remains no cure for the disease and its biological mechanisms are not well understood. Elevated intraocular pressure (IOP) is a major risk factor for the disease, but many patients with glaucoma have normal eye pressure and still lose vision.
In a new study published this past month in Nature Communications, researchers from Mass Eye and Ear, led by Ayellet Segrè, PhD, conducted a comprehensive study that combined genetic discoveries from a large cross-ancestry genome-wide association study meta-analysis of POAG, led by Janey Wiggs, MD, PhD, ...
2024-02-16
LAWRENCE — No one can do everything. Yet that is exactly what many school leaders feel like they must do. A new book from a pair of school leaders and scholars aims to help those who often feel overwhelmed focus on what they can and should do and how to help teachers and students lead schools to reaching their full potential.
“Focused: Understanding, Negotiating, and Maximizing Your Influence as a School Leader,” by Jim Watterston and Yong Zhao, aims to help educational administrators guide schools to success without getting ...
2024-02-16
Testing wastewater to assess the spread of the COVID-19 virus became common and well-publicized during the pandemic, but it has been focused mostly on urban areas.
The Appalachian Regional Commission (ARC) has awarded $400,000 to Virginia Tech, with an additional $50,000 to Virginia Tech from the Virginia Department of Health, for a two-year project to identify and implement improved and new methods to detect pathogens for multiple diseases in the wastewater of rural communities.
“My work and research have primarily been focused on rural areas, and prior to the pandemic, most ...
2024-02-16
The efficiency of oxygen supply to tissues is a factor in the severity of important diseases such as Covid-19 and heart conditions.
Scientists already know that the relationship between the length of a person’s index and ring fingers, known as the 2D:4D ratio is correlated with performance in distance running, age at heart attack and severity of Covid-19.
Now Swansea University digit ratio expert Professor John Manning has been working with colleagues to look more closely at the subject.
Their findings have just been published by the prestigious American Journal of Human ...
2024-02-16
In the past decade, humanity has seen the birth and expansion of a commercial space sector with new, private players, addressing technological challenges - from space launch to communication and satellite imagery of Earth. Last year, the global space industry skyrocketed launching more than 2,660* satellites into orbit, and, into the universe, interplanetary probes, landers, and much more. In the United States, SpaceX was responsible for almost 90% of these launches. In parallel to this progression is the expansion of more than 70 countries** demonstrating space capabilities. It affirms the general consensus and understanding ...
2024-02-16
Researchers from the University of Seville have investigated how the flowering of 51 species of shrubs, bushes and trees has changed over the last 35 years in Doñana National Park so as to understand how plant communities are responding to climate change in the south of the Iberian Peninsula. Over this period, the average temperature in the area has increased by 1 °C and the minimum temperature by as much as 2 °C. As a result, the community’s peak flowering time, the time when the greatest number of species are in flower, has been brought forward by 22 days, from 9 May to 17 April.
This earlier flowering is not ...
2024-02-16
A team of researchers are encouraging us to swap textbooks for games, as they drive the application of games in learning, engagement and research.
Known as ‘serious games’, these games are designed for more than just entertainment. Ranging from digital applications to physical board games, they are developed for learning, problem solving, raising awareness, research, and stakeholder engagement – with potential in both schools and workplaces. A key application will be for educating people on sustainable development and climate change.
Experts leading in the field at the Universities of Warwick, Cardiff, York, and Sussex, ...
2024-02-16
Understanding how the poor deal with the effects of the economic crisis into which Brazil plunged in 2014 was the aim of the research project “The crisis seen from the periphery: struggle for social mobility in the frontiers of (i)legality” conducted by Leonardo de Oliveira Fontes with FAPESP’s support (19/13125-2 and 21/13970-4). An article published in the International Journal of Urban and Regional Research is one of the results of the investigation.
Fontes is currently a professor in the Department of Sociology ...
LAST 30 PRESS RELEASES:
[Press-News.org] NIH trial data underpins FDA approval of omalizumab for food allergy
